Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
PTGX holding history
Protagonist Therapeutics, Inc in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings
- Shares (Q2 2026)
- 398,994
- Value
- $48.9M
- % of portfolio
- 0.1%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 398,994 | $48.9M | 0.1% | +235,535+144.1% | Added | Holders |
| Q1 2026 | 163,459 | $17.2M | 0.1% | +163,459 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −275,787−100.0% | Sold out | Holders |
| Q1 2022 | 275,787 | $6.53M | <0.1% | +112,123+68.5% | Added | Holders |
| Q4 2021 | 163,664 | $5.60M | <0.1% | +163,664 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −138,608−100.0% | Sold out | Holders |
| Q2 2021 | 138,608 | $6.22M | <0.1% | +138,608 | New | Holders |